Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
5 Breakout Stocks Ready to Surge Higher
By Roberto Pedone
May 31, 2013 2:02 PM EDT
INVESTING
4 Hot Stocks to Trade (or Not)
By Jonas Elmerraji
May 9, 2013 1:30 PM EDT
INVESTING
5 Big Stocks to Trade (or Not)
By Jonas Elmerraji
Mar 19, 2013 2:27 PM EDT
INVESTING
4 Biotech Stocks Under $5 to Watch
By Roberto Pedone
Mar 15, 2013 7:00 AM EDT
STOCKS
Biotech Stock Mailbag: Delcath, Navidea, Affymax, Ziopharm
By Adam Feuerstein
Mar 15, 2013 6:00 AM EDT
INVESTING
5 Stocks Ready to Break Out
By Roberto Pedone
Mar 8, 2013 2:20 PM EST
INVESTING
5 Stocks Poised for Breakouts
By Roberto Pedone
Mar 1, 2013 2:39 PM EST
MARKETS
3 Stocks Pushing The Drugs Industry Lower
By TheStreet Wire
Feb 25, 2013 12:05 PM EST
STOCKS
Affymax Is Done. RIP.
By Adam Feuerstein
Feb 25, 2013 10:35 AM EST
STOCKS
10 Best-Performing Biopharma Stocks of 2012 and Their 2013 Outlook
By Adam Feuerstein
Nov 27, 2012 6:40 AM EST
INVESTING
3 Stocks Rising on Unusual Volume
By Roberto Pedone
Nov 9, 2012 3:47 PM EST
MARKETS
4 Health Care Stocks Rising on Big Volume
By Roberto Pedone
Oct 22, 2012 2:36 PM EDT
MARKETS
4 Stocks Moving Higher With Volume
By Roberto Pedone
Oct 10, 2012 1:48 PM EDT
JIM CRAMER
Cramer's 'Mad Money' Recap: When Progress Isn't Good
By Scott Rutt
Sep 18, 2012 8:11 PM EDT
STOCKS
Nektar Therapeutics Is a Short
By Martin Shkreli
Sep 12, 2012 7:08 AM EDT
MARKETS
4 Big-Volume Stocks Surging Higher
By Roberto Pedone
Aug 20, 2012 1:50 PM EDT
STOCKS
Biotech Stock Mailbag: Amarin or Arena Takeout?
By Adam Feuerstein
Jul 6, 2012 6:00 AM EDT
INVESTING
8 Stocks Rising on Monster Volume
By Roberto Pedone
Apr 2, 2012 1:01 PM EDT
STOCKS
Biotech Stock Mailbag: MAP Pharma, Affymax
By Adam Feuerstein
Mar 30, 2012 5:30 AM EDT
INVESTING
8 Stocks Rising on Huge Volume
By Roberto Pedone
Mar 23, 2012 2:08 PM EDT
STOCKS
Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest
By Adam Feuerstein
Mar 23, 2012 5:30 AM EDT
VIDEO
The Next Big Thing in Biotech: FDA Decisions
By Gregg Greenberg
Mar 23, 2012 5:00 AM EDT
INVESTING
Biotech Stock Chat: Recap
By Adam Feuerstein
Mar 15, 2012 11:54 AM EDT
INVESTING
5 Stocks Ready to Soar on Bullish Earnings
By Roberto Pedone
Mar 13, 2012 6:12 AM EDT
STOCKS
More Biotech Twitter Mailbag: Orexigen, Affymax, YM Bio, Spectrum & More
By Adam Feuerstein
Feb 29, 2012 7:03 AM EST